Bpifrance
All figures cover the European funds tracked here since 1 January 2025, whether closed or still raising, and are compiled from public sources.
- Tracked funds
- 1
- Reported volume
- €207m
- Latest public closing
- 17 Sept 2026
Reported volume sums the public fund amounts tracked here, not the manager's firm-wide assets under management, so it may differ from totals on the manager's website.
French public investment bank supporting businesses with financing and investment, including equity and fund-of-funds activity.
Focus: Direct and indirect equity investment in innovative companies, growth capital for SMEs and mid-caps, fund-of-funds across stages
17 September 2026: InnoBio 3, a life-sciences fund managed by Bpifrance, closed at its final size of €207m (Bpifrance press release).
Tracked funds
- 207.0
Backs innovative biotech companies with differentiated assets through a partnership model linking pharma groups, investors and scientific experts.
- Health & Bio
- Fund 3
- 17 Sept 2026
- Bpifrance
- Bpifrance